Members: Dr. Sandra Johnston

404 Not Found

404 Not Found


Research Scientist

PhD Nursing Science

Dr. Sandra Johnston (PhD Nursing Science) joined the Swanson lab in early 2012 as a research scientist. She brings a wealth of clininical trial and clinical experience to the lab.

Outside of work, Sandra can be found hiking, camping, and gardening.

Sandra is very dedicated to solving the problem of glioma growth and improvement survival.


BS Nursing Truman State University

MS Clinical Nurse Specialty Texas Womans University

PhD Nursing Science University of Washington

PostDoc Fellowship Biomedical and Health Informatics University of Washington

Papers Under Review:

Invasion and Proliferation Kinetics in Enhancing Gliomas Predict IDH1 Mutation Status Anne L. Baldock, Kevin Yagle, Donald E. Born, Sunyoung Ahn, Andrew D. Trister, Maxwell Neal, Sandra K. Johnston, Carly Bridge, David Basanta,  Jacob Scott, Maciej M. Mrugala, Jason K. Rockhill, Russell C. Rockne,  Kristin R. Swanson. Under review Journal of Neuroonology.

Increased Temozolomide Efficacy After Stem Cell Gene Therapy in Glioblastoma Jennifer E. Adair Ph.D., Sandra K. Johnston Ph., Brian C. Beard Ph.D., Laura A. Guyman, M.S., Anne L. Baldock, BS, Carly A. Bridge, N.D., Andrea Hawkins-Daarud, Ph.D. Jennifer L. Gori, Ph.D., Barry E. Storer, Ph.D.,Donald Born M.D., Ph.D, Luis F. Gonzalez-Cuyar, M.D.,Jason K. Rockhill M.D., Ph.D.,Daniel L. Silbergeld M.D., Maciej Mrugala M.D., Ph.D., M.P.H.,Russell C. Rockne Ph.D.,Hans-Peter Kiem M.D.and  Kristin R. Swanson, Ph.D.. Under review NEJM.


Johnston SK, Bridge CA, Rockne RC, Guyman L, Baldock AL, Rockhill JK, Mrugala MM, Beard BC, Adair JE, Kiem HP, Swanson KR. Enabling the Detection of Treatment Benefit through Patient-Specific Mathematical

Modeling:  Analysis of  Chemoprotective Hematopoietic Stem Cell Gene Therapy in Glioblastomas.  Proceeding of the Society for Neuro-Oncology 17th Annual Meeting, Washington, DC. November 15-18, 2012. Poster Presentation.  Neuro-Oncology, Volume 14 suppl 6 October 2012, NO-69.

Neuro Oncol (2012) 14(suppl 6): vi129-vi132 doi:10.1093/neuonc/nos237,  Baldock A, Yagle K, Ahn S, Johnston S, Mrugala M, Rockhill J, Born D, Swanson P, Trister A, Rockne R, Swanson KR. Invasion and Proliferation Kinetics Predict IDH-1 Mutation in Contrast-Enhancing Gliomas. Proceeding of the Society for Neuro-Oncology 17th Annual Meeting, Washington, DC. November 15-18, 2012. Podium Presentation. RB-14 Neuro Oncol (2012) 14(suppl 6): vi129-vi132 doi:10.1093/neuonc/nos237

Characteristics of long-term survivors in glioblastoma. Carly A  Bridge,  Anne Baldock, Priya Kumther, Paul  Dilfer, Sandra K Johnston, Joshua Jacobs, David Corwin, Laura Guyman, Russell Rockne, Adam Sonabend, Michael Cloney, Peter Canoll, Kristin R Swanson. For presentation at SNO 2013


Patient-specific mathematical modeling as a precision-medicine approach to evaluating therapeutic gains of a novel chemoprotection treatment in newly diagnosed glioblastoma. Sandra K. Johnston, Jennifer E. Adair, Carly Bridge, Laura Guyman, Andrea Hawkins-Daarud, Russell Rockne, Anne Baldock, Jason K. Rockhill, Maciej M. Mrugala, Brian C. Beard, Hans-Peter Kiem, Kristin Swanson. J Clin Oncol 31, 2013 (suppl; abstr e13041).

© 2017 Mathematical NeuroOncology (MNO). Website designed by